These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35382760)

  • 1. Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression.
    Restrepo JM; Torres-Canchala L; Londoño H; Manzi E; Somers MJG
    BMC Nephrol; 2022 Apr; 23(1):131. PubMed ID: 35382760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.
    Argiolas D; Carta E; Mascia G; Michittu MB; Piredda GB
    Transplant Proc; 2019; 51(1):223-225. PubMed ID: 30580884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
    Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
    Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients.
    Straatmann C; Kallash M; Killackey M; Iorember F; Aviles D; Bamgbola O; Carson T; Florman S; Vehaskari MV
    Pediatr Transplant; 2014 Feb; 18(1):29-34. PubMed ID: 24266922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis.
    Dirim AB; Demir E; Guller N; Safak S; Artan AS; Oto OA; Ozluk Y; Ozturk S; Yazici H; Kalayoglu-Besisik S; Turkmen A
    J Clin Apher; 2022 Aug; 37(4):376-387. PubMed ID: 35535432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of peri-transplant plasmapheresis in the prevention of recurrent FSGS.
    Verghese PS; Rheault MN; Jackson S; Matas AJ; Chinnakotla S; Chavers B
    Pediatr Transplant; 2018 May; 22(3):e13154. PubMed ID: 29388290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
    Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
    Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort.
    Allard L; Kwon T; Krid S; Bacchetta J; Garnier A; Novo R; Deschenes G; Salomon R; Roussey G; Allain-Launay E
    Nephrol Dial Transplant; 2018 Jun; 33(6):954-963. PubMed ID: 28992235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression.
    Schachter ME; Monahan M; Radhakrishnan J; Crew J; Pollak M; Ratner L; Valeri AM; Stokes MB; Appel GB
    Clin Nephrol; 2010 Sep; 74(3):173-81. PubMed ID: 20860901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide.
    Kershaw DB; Sedman AB; Kelsch RC; Bunchman TE
    Clin Transplant; 1994 Dec; 8(6):546-9. PubMed ID: 7865917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis.
    Fencl F; Vondrák K; Rosík T; Zieg J; Chadimová M; Háček J; Dušek J; Seeman T
    Minerva Pediatr; 2016 Oct; 68(5):348-54. PubMed ID: 26041001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis.
    Garcia CD; Bittencourt VB; Tumelero A; Antonello JS; Malheiros D; Garcia VD
    Transplant Proc; 2006; 38(6):1904-5. PubMed ID: 16908318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early use of plasmapheresis for recurrent post-transplant FSGS.
    Pradhan M; Petro J; Palmer J; Meyers K; Baluarte HJ
    Pediatr Nephrol; 2003 Sep; 18(9):934-8. PubMed ID: 12836097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of FSGS after Kidney Transplantation in Adults.
    Uffing A; Pérez-Sáez MJ; Mazzali M; Manfro RC; Bauer AC; de Sottomaior Drumond F; O'Shaughnessy MM; Cheng XS; Chin KK; Ventura CG; Agena F; David-Neto E; Mansur JB; Kirsztajn GM; Tedesco-Silva H; Neto GMV; Arias-Cabrales C; Buxeda A; Bugnazet M; Jouve T; Malvezzi P; Akalin E; Alani O; Agrawal N; La Manna G; Comai G; Bini C; Muhsin SA; Riella MC; Hokazono SR; Farouk SS; Haverly M; Mothi SS; Berger SP; Cravedi P; Riella LV
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):247-256. PubMed ID: 31974287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis.
    Boonpheng B; Hansrivijit P; Thongprayoon C; Mao SA; Vaitla PK; Bathini T; Choudhury A; Kaewput W; Mao MA; Cheungpasitporn W
    World J Transplant; 2021 Jul; 11(7):303-319. PubMed ID: 34316454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
    Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN
    Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts.
    Kandus A; Ponikvar R; Buturović-Ponikvar J; Bren AF; Oblak M; Mlinšek G; Kmetec A; Arnol M
    Ther Apher Dial; 2013 Aug; 17(4):438-43. PubMed ID: 23931886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation.
    Al Shamsi HR; Shaheen I; Aziz D
    Transplant Rev (Orlando); 2022 Jan; 36(1):100675. PubMed ID: 34952298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients.
    Gohh RY; Yango AF; Morrissey PE; Monaco AP; Gautam A; Sharma M; McCarthy ET; Savin VJ
    Am J Transplant; 2005 Dec; 5(12):2907-12. PubMed ID: 16303004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.